Navigation Links
North America Leads Cancer Tumor Profiling Market 2018 Forecasts in a New Research Report at RnRMarketResearch.com
Date:9/27/2013

Dallas, Texas (PRWEB) September 27, 2013

Cancer/Tumor profiling is a promising market and is witnessing significant growth in the healthcare industry. It is poised to grow rapidly in a range of application areas, including biomarker discovery and prognosis. The global cancer/tumor profiling market is valued at $14.99 billion in 2013 and is expected to reach $35.03 billion by 2018.

A list of tests (for example, Barium X-ray, Blood tests, Bone marrow, Cystoscopy, Lumbar puncture) is available, used for diagnosing specific types of cancer. Also, there are different treatment options for cancer, including chemotherapy, hormone therapy, surgery, radiotherapy, bisphosphonates, bone marrow and stem cell transplants, and biological therapies. Despite the availability of different treatment options, profiling a cancer/tumor, that is, knowledge about a patient’s cancer/tumor profile may identify genomic alterations that will help the physician to guide the patient to a systemic therapy with a higher likelihood of success. This will rule out those that are unlikely to be successful, on an individual basis, thereby minimizing the trial and error process.

Complete report available @ http://www.rnrmarketresearch.com/cancertumor-profiling-market-applications-personalized-medicine-diagnostics-biomarker-discovery-prognosis-research-technologies-ngs-qpcr-ihc-fishcish-microarray-segments-genomics-pr-market-report.html .

Every cancer cell has got its own pattern of active genes and proteins; therefore, molecular profiling tests for a number of different biomarkers in the DNA of a tissue sample will assist in better diagnosing and staging the cancer on an individual basis. This provides the doctors with better information to develop a personalized treatment plan for a patient, which is known as personalized medicine.

There are quite a number of research groups working on diverse applications of cancer/tumor profiling targeting different cancer types, particularly in studying key target molecules involved in the pathogenesis. Hundreds of research articles have been published and a lot of patents granted and filed for this field of biology.

The cancer/tumor profiling market is analyzed both in terms of qualitative, that is, technological and quantitative, that is, revenue and perspectives. The technological analysis includes discussion on the advantages and capabilities of cancer/tumor profiling technologies and the various applications where cancer/tumor profiling can find a strong position in the healthcare industry. The market revenue analysis includes market segmentation and the expected market position by 2018, with the projected growth rate.

The cancer/tumor profiling market is classified by geography, applications, technologies, and segment types. The technologies section is further segmented into Next-Generation Sequencing, Quantitative PCR, Immunohistochemistry, FISH/CISH, and Microarray. Though personalized medicine is highlighted as the prime application area of cancer/tumor profiling, there are many opportunities in Diagnostics, Biomarker Discovery, Prognosis, and Research applications.

Besides a discussion on the properties and advantages of cancer/tumor profiling in the technological analysis, the basics on the correlation of cancer with genomics, proteomics, Metabolomics, and epigenetics are also discussed. Further, the research network including academic universities and biotech companies with their research contributions are also provided. The complete value chain of the cancer/tumor profiling market is schematically represented and the significance of each stakeholder has been briefed.

Apart from the technological and market analysis, the investor climate has been assessed by tracking the complete investor network and collecting data on funds/grants and investments made towards the cancer/tumor profiling. Insights on current and future technological investment trends have also been discussed.

The adoption and developmental potential of the cancer/tumor profiling technology market has been discussed on a geographic basis, that is, North America, Europe, Asia, and Rest of the World, by taking select countries that are poised to have a greater market value during the forecast period.

In brief, this research report provides:

  •     A detailed description of the global technology developments and evolving trends in the cancer/tumor profiling field with key importance on research innovations, collaborative efforts, and investments for cancer/tumor profiling
  •     An impact analysis of major drivers and restraints influencing the adoption and growth of the cancer/tumor profiling market from 2013 to 2018
  •     Porter’s five forces analysis and GAP analysis
  •     Market size – global market forecast for 2013-2018 analysis and strategic recommendations for technology/product developers
  •     Competitive landscape, including key industry activities (for example, mergers, acquisitions, partnerships, collaborations, and agreements) and an analysis of key patents on the segment types.

Purchase a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=117219 .

Browse more reports on Cancer Diagnostics Market @ http://www.rnrmarketresearch.com/reports/life-sciences/diagnostics/in-vitro-diagnostics-ivd/cancer-diagnostics .

About Us:
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

Explore industry research reports focused on China at http://chinamarketresearchreports.com/ .

Read the full story at http://www.prweb.com/releases/cancer-tumor-profiling/market-and-analysis/prweb11170453.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Northern Virginia Real Estate Company Pasquali Realty Group Announces Home Sales Up in August
2. California Dental Group Hosts 8th Annual Dentistry Event in North Hollywood CA Providing Emergency Dental Care at No Cost to Patients
3. Tools4ever Launches Reseller Program in North America
4. T.E.N. Announces Nominees for the 2013 ISE® North America Awards
5. Domtar Corporation to Locate North American Operations Center in Pitt County, NC
6. North Shore Eye Care Adds Ophthalmologists Lawrence Buono, MD Christine Speer-Buono, MD To Medical Staff
7. Northern New Jersey Water Softener Company Announces Water Softener Trade-In Deal for Home and Business Owners
8. Crystal Meth Epidemic Reported from Inside North Korea
9. Bodnar Chiropractic Center of Alexandria, VA Receives Top Honors for 2013 from Northern Virginia Magazine
10. North American Spine Leading the Way During Pain Awareness Month
11. Dr. Christine Fialka-Eshenko Announces Sponsorship Opportunities for Northwest Dental Exposition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... 05, 2016 , ... TransWipe Volume 3 is a set of 30 professional ... TransWipe preset between two video clips to instantly add a unique transition to any ... customizable color and orientation options. TransWipe Volume 3 is a Final Cut Pro X ...
(Date:5/5/2016)... ... 2016 , ... The U.S. Food and Drug Administration today ... submit their products through an arduous federal approval process. The rules, which treat ... market since February 15, 2007. That would essentially ban 99 percent of all ...
(Date:5/5/2016)... ... May 05, 2016 , ... Spring Fertility , the ... and with egg freezing, today announced the grand opening of its first location ... care, Spring Fertility offers both fertility preservation (egg, sperm, embryo, and testicular and ...
(Date:5/5/2016)... , ... May 05, 2016 , ... Derrin Doty Group ... families of Bremerton, Port Orchard and communities west of Seattle. The insurance provider’s caring ... year local girl who died suddenly due to complications from the flu, that they ...
(Date:5/5/2016)... ... May 05, 2016 , ... A recent survey by the ... challenges in getting employees to understand and use the free preventive care benefits available ... leading non-profit business groups of large, self-insured public and private employers, MBGH found that ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... -- Research and Markets has announced the addition of ... Markets"  report to their offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... current Positron Emission Tomography (PET) scanner and cyclotron install base ... France , Germany , ... and the United Kingdom . Along with ...
(Date:5/5/2016)... 5, 2016 Research ... "Europe Systemic Lupus Erythematosus Market and Competitive ... offering.       (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Europe Systemic Lupus Erythematosus Market and Competitive ... into Systemic Lupus Erythematosus pipeline products, Systemic ...
(Date:5/4/2016)... ZIONA, Israel , May 4, 2016 ... BVXV) announced today that BiondVax,s CEO, Dr. Ron Babecoff ... in New York City . ... 10:30am at Pioneers 2016, a conference presented by Joseph ... Palace Hotel. The BiondVax presentation that Dr. Babecoff ...
Breaking Medicine Technology: